Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cells in Low Risk Acute Myeloid Leukemia With Nucleophosmin Gene Mutation: a Study of the Tumor Microenvironment and Its Contribution to the Outcome

NCT07379528 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.

NCT NCT07379528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cells in Low Risk Acute Myeloid Leukemia With Nucleophosmin Gene Mutation: a Study of the Tumor Microenvironment and Its Contribution to the Outcome
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase
Observational
Overall status
Completed
Start date
March 15, 2023
Completion date
March 15, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukaemia (aml)